| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 17 | 2026 | 1306 | 3.700 |
Why?
|
| Glioblastoma | 11 | 2026 | 372 | 2.960 |
Why?
|
| Neoplastic Stem Cells | 11 | 2026 | 330 | 2.800 |
Why?
|
| Chromatin | 9 | 2026 | 500 | 2.190 |
Why?
|
| Glioma | 5 | 2026 | 496 | 1.880 |
Why?
|
| Medulloblastoma | 5 | 2025 | 376 | 1.250 |
Why?
|
| Caenorhabditis elegans | 6 | 2011 | 245 | 1.180 |
Why?
|
| Gene Expression Profiling | 8 | 2026 | 1806 | 1.040 |
Why?
|
| Caenorhabditis elegans Proteins | 6 | 2011 | 103 | 1.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 13 | 2026 | 2008 | 1.010 |
Why?
|
| Histones | 6 | 2026 | 542 | 0.930 |
Why?
|
| Polyamines | 1 | 2025 | 37 | 0.920 |
Why?
|
| Hypoxia | 2 | 2026 | 247 | 0.890 |
Why?
|
| Chromatin Assembly and Disassembly | 3 | 2026 | 121 | 0.780 |
Why?
|
| Transcriptome | 2 | 2026 | 1111 | 0.720 |
Why?
|
| Synapses | 1 | 2025 | 442 | 0.720 |
Why?
|
| Ependymoma | 4 | 2026 | 137 | 0.700 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2022 | 237 | 0.650 |
Why?
|
| Butyrophilins | 1 | 2020 | 1 | 0.640 |
Why?
|
| Cell Self Renewal | 2 | 2021 | 48 | 0.630 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2020 | 82 | 0.620 |
Why?
|
| Longevity | 3 | 2011 | 176 | 0.600 |
Why?
|
| Cerebellar Neoplasms | 4 | 2025 | 316 | 0.600 |
Why?
|
| Genes, Homeobox | 2 | 2023 | 61 | 0.570 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 679 | 0.550 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2026 | 269 | 0.540 |
Why?
|
| Carcinogenesis | 1 | 2020 | 336 | 0.540 |
Why?
|
| Mutation | 10 | 2026 | 6092 | 0.530 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 1046 | 0.500 |
Why?
|
| Cell Differentiation | 7 | 2026 | 1919 | 0.480 |
Why?
|
| Neurons | 1 | 2025 | 2022 | 0.460 |
Why?
|
| Epigenesis, Genetic | 6 | 2024 | 759 | 0.460 |
Why?
|
| Genes, Helminth | 3 | 2011 | 19 | 0.450 |
Why?
|
| Cancer Care Facilities | 1 | 2025 | 32 | 0.450 |
Why?
|
| DNA Methylation | 6 | 2024 | 1080 | 0.430 |
Why?
|
| Cell Proliferation | 9 | 2026 | 2461 | 0.420 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 851 | 0.420 |
Why?
|
| Anion Transport Proteins | 2 | 2011 | 31 | 0.420 |
Why?
|
| Animals | 24 | 2026 | 33844 | 0.420 |
Why?
|
| Medical Oncology | 1 | 2025 | 240 | 0.390 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 1582 | 0.390 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2019 | 1268 | 0.380 |
Why?
|
| Cell Line, Tumor | 9 | 2026 | 3715 | 0.370 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2012 | 82 | 0.360 |
Why?
|
| Humans | 32 | 2026 | 130432 | 0.350 |
Why?
|
| Genes, Mitochondrial | 1 | 2011 | 18 | 0.350 |
Why?
|
| Precision Medicine | 1 | 2025 | 384 | 0.350 |
Why?
|
| SOXB1 Transcription Factors | 2 | 2024 | 57 | 0.310 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2026 | 167 | 0.310 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 178 | 0.310 |
Why?
|
| Mice | 14 | 2026 | 18210 | 0.300 |
Why?
|
| Pheromones | 1 | 2009 | 9 | 0.290 |
Why?
|
| Adenosine Triphosphate | 1 | 2010 | 267 | 0.290 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3406 | 0.290 |
Why?
|
| Mitochondria | 2 | 2011 | 776 | 0.280 |
Why?
|
| DNA-Binding Proteins | 2 | 2015 | 1946 | 0.280 |
Why?
|
| Energy Metabolism | 2 | 2011 | 801 | 0.280 |
Why?
|
| Mice, SCID | 4 | 2025 | 585 | 0.270 |
Why?
|
| Whole Genome Sequencing | 2 | 2020 | 358 | 0.260 |
Why?
|
| Genome, Human | 3 | 2024 | 1314 | 0.260 |
Why?
|
| Tumor Cells, Cultured | 3 | 2019 | 975 | 0.260 |
Why?
|
| Signal Transduction | 5 | 2026 | 4669 | 0.260 |
Why?
|
| Neoplasms | 3 | 2025 | 2973 | 0.250 |
Why?
|
| Rhombencephalon | 2 | 2026 | 63 | 0.250 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2019 | 1000 | 0.250 |
Why?
|
| Fatty Acids | 1 | 2009 | 373 | 0.240 |
Why?
|
| Cell Hypoxia | 1 | 2026 | 85 | 0.240 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2026 | 27 | 0.240 |
Why?
|
| Insulin | 1 | 2011 | 1140 | 0.240 |
Why?
|
| Mediator Complex | 1 | 2026 | 62 | 0.230 |
Why?
|
| Oxygen | 2 | 2026 | 550 | 0.230 |
Why?
|
| Mice, Inbred NOD | 3 | 2015 | 302 | 0.230 |
Why?
|
| Meninges | 1 | 2025 | 22 | 0.220 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2020 | 1071 | 0.220 |
Why?
|
| Child | 7 | 2025 | 26105 | 0.220 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2025 | 22 | 0.220 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 384 | 0.220 |
Why?
|
| Promoter Regions, Genetic | 3 | 2018 | 1210 | 0.220 |
Why?
|
| Apoptosis | 1 | 2011 | 1829 | 0.210 |
Why?
|
| Androgens | 1 | 2026 | 245 | 0.210 |
Why?
|
| Transcription Factors | 4 | 2025 | 2420 | 0.200 |
Why?
|
| Genomics | 2 | 2023 | 1616 | 0.200 |
Why?
|
| Tumor Microenvironment | 2 | 2025 | 707 | 0.190 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2023 | 79 | 0.190 |
Why?
|
| Prognosis | 4 | 2023 | 4861 | 0.190 |
Why?
|
| Meningeal Neoplasms | 1 | 2025 | 218 | 0.190 |
Why?
|
| RNA, Long Noncoding | 1 | 2024 | 217 | 0.180 |
Why?
|
| Astrocytoma | 1 | 2022 | 101 | 0.180 |
Why?
|
| Epigenomics | 2 | 2020 | 181 | 0.170 |
Why?
|
| Computational Biology | 1 | 2026 | 862 | 0.170 |
Why?
|
| Genomic Structural Variation | 1 | 2022 | 96 | 0.160 |
Why?
|
| Lactobacillus johnsonii | 1 | 2020 | 2 | 0.160 |
Why?
|
| Larva | 3 | 2011 | 244 | 0.160 |
Why?
|
| Inosine | 1 | 2020 | 7 | 0.160 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2021 | 137 | 0.160 |
Why?
|
| Intestinal Neoplasms | 1 | 2020 | 36 | 0.160 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2022 | 742 | 0.160 |
Why?
|
| Bifidobacterium | 1 | 2020 | 65 | 0.160 |
Why?
|
| Translocation, Genetic | 1 | 2022 | 344 | 0.150 |
Why?
|
| GPI-Linked Proteins | 1 | 2020 | 109 | 0.150 |
Why?
|
| Forkhead Transcription Factors | 3 | 2022 | 373 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 302 | 0.150 |
Why?
|
| Mitochondrial Proteins | 2 | 2011 | 285 | 0.150 |
Why?
|
| B7 Antigens | 1 | 2019 | 14 | 0.150 |
Why?
|
| Disease | 1 | 2020 | 121 | 0.150 |
Why?
|
| Female | 11 | 2026 | 70362 | 0.150 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 106 | 0.150 |
Why?
|
| Genetic Heterogeneity | 1 | 2019 | 133 | 0.140 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 665 | 0.140 |
Why?
|
| Cell Lineage | 2 | 2017 | 341 | 0.140 |
Why?
|
| Drosophila | 1 | 2022 | 772 | 0.140 |
Why?
|
| Genome | 1 | 2020 | 453 | 0.140 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 899 | 0.140 |
Why?
|
| Telomerase | 1 | 2018 | 153 | 0.130 |
Why?
|
| Male | 8 | 2026 | 64470 | 0.130 |
Why?
|
| Germ-Line Mutation | 1 | 2020 | 372 | 0.130 |
Why?
|
| Cell Tracking | 1 | 2017 | 15 | 0.130 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 242 | 0.130 |
Why?
|
| Databases, Genetic | 1 | 2020 | 500 | 0.130 |
Why?
|
| CpG Islands | 2 | 2018 | 337 | 0.130 |
Why?
|
| Drosophila Proteins | 1 | 2022 | 776 | 0.120 |
Why?
|
| Heterochromatin | 2 | 2026 | 52 | 0.120 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2010 | 963 | 0.120 |
Why?
|
| Oxidative Stress | 2 | 2011 | 795 | 0.120 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2020 | 481 | 0.120 |
Why?
|
| Immunotherapy | 1 | 2020 | 760 | 0.110 |
Why?
|
| DNA Copy Number Variations | 1 | 2020 | 1021 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1486 | 0.110 |
Why?
|
| Drug Design | 1 | 2015 | 162 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 1367 | 0.110 |
Why?
|
| Canada | 1 | 2025 | 325 | 0.100 |
Why?
|
| RNA Interference | 1 | 2015 | 493 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2013 | 54 | 0.100 |
Why?
|
| Transfection | 1 | 2015 | 960 | 0.100 |
Why?
|
| Melanoma | 1 | 2020 | 926 | 0.100 |
Why?
|
| Hedgehog Proteins | 1 | 2014 | 198 | 0.100 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2013 | 92 | 0.100 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 902 | 0.100 |
Why?
|
| Information Dissemination | 1 | 2025 | 194 | 0.090 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1828 | 0.090 |
Why?
|
| Phenotype | 4 | 2021 | 4475 | 0.090 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 831 | 0.090 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2013 | 149 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 223 | 0.090 |
Why?
|
| Polycomb Repressive Complex 2 | 2 | 2026 | 32 | 0.090 |
Why?
|
| bcl-X Protein | 1 | 2011 | 32 | 0.080 |
Why?
|
| Subcellular Fractions | 1 | 2011 | 89 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 2826 | 0.080 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 132 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 1547 | 0.080 |
Why?
|
| Aging | 2 | 2010 | 1244 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2012 | 1016 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 525 | 0.080 |
Why?
|
| Pediatrics | 1 | 2020 | 1240 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 382 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 365 | 0.080 |
Why?
|
| Germ Cells | 1 | 2011 | 201 | 0.080 |
Why?
|
| Adult | 3 | 2022 | 31124 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 995 | 0.080 |
Why?
|
| Life Expectancy | 1 | 2010 | 63 | 0.080 |
Why?
|
| Temperature | 1 | 2010 | 290 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1596 | 0.070 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 1800 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 692 | 0.070 |
Why?
|
| Time Factors | 2 | 2015 | 6204 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 526 | 0.070 |
Why?
|
| Models, Animal | 1 | 2010 | 452 | 0.070 |
Why?
|
| Protein Binding | 1 | 2011 | 1656 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 372 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2013 | 888 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2014 | 3469 | 0.060 |
Why?
|
| Polycomb-Group Proteins | 1 | 2026 | 24 | 0.060 |
Why?
|
| Cell Line | 1 | 2011 | 2558 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2009 | 452 | 0.060 |
Why?
|
| Histone Demethylases | 1 | 2026 | 40 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1589 | 0.060 |
Why?
|
| Methionine | 1 | 2026 | 95 | 0.060 |
Why?
|
| Methylation | 1 | 2026 | 198 | 0.060 |
Why?
|
| Androgen Antagonists | 1 | 2026 | 104 | 0.060 |
Why?
|
| Pluripotent Stem Cells | 1 | 2026 | 78 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2025 | 26 | 0.060 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2025 | 40 | 0.060 |
Why?
|
| Metencephalon | 1 | 2025 | 9 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 623 | 0.060 |
Why?
|
| Animals, Genetically Modified | 1 | 2006 | 326 | 0.050 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2026 | 210 | 0.050 |
Why?
|
| Infratentorial Neoplasms | 1 | 2024 | 33 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2026 | 322 | 0.050 |
Why?
|
| Biglycan | 1 | 2023 | 6 | 0.050 |
Why?
|
| Loss of Function Mutation | 1 | 2025 | 170 | 0.050 |
Why?
|
| Spatial Analysis | 1 | 2023 | 26 | 0.050 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2022 | 3 | 0.050 |
Why?
|
| Receptors, Androgen | 1 | 2026 | 407 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2015 | 14948 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 2397 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2026 | 710 | 0.040 |
Why?
|
| Young Adult | 1 | 2015 | 9997 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2021 | 58 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2022 | 218 | 0.040 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2020 | 11 | 0.040 |
Why?
|
| CTLA-4 Antigen | 1 | 2020 | 65 | 0.040 |
Why?
|
| Neoplasms, Experimental | 1 | 2020 | 200 | 0.040 |
Why?
|
| B7-H1 Antigen | 1 | 2020 | 129 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2022 | 560 | 0.040 |
Why?
|
| Antibodies | 1 | 2020 | 320 | 0.040 |
Why?
|
| Gene Expression | 1 | 2022 | 1485 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2018 | 282 | 0.030 |
Why?
|
| Stochastic Processes | 1 | 2017 | 34 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 350 | 0.030 |
Why?
|
| Clone Cells | 1 | 2017 | 152 | 0.030 |
Why?
|
| Adolescent | 1 | 2015 | 20732 | 0.030 |
Why?
|
| Heterografts | 1 | 2017 | 191 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 358 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 626 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2026 | 4669 | 0.030 |
Why?
|
| Plicamycin | 1 | 2014 | 4 | 0.030 |
Why?
|
| Patched Receptors | 1 | 2014 | 27 | 0.030 |
Why?
|
| Smoothened Receptor | 1 | 2014 | 31 | 0.030 |
Why?
|
| Infant | 2 | 2024 | 13230 | 0.030 |
Why?
|
| Antigens, Nuclear | 1 | 2014 | 52 | 0.030 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2013 | 5 | 0.030 |
Why?
|
| Neuropeptides | 1 | 2014 | 110 | 0.030 |
Why?
|
| Gene Fusion | 1 | 2013 | 57 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2014 | 231 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 156 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 251 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2013 | 423 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2014 | 209 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 421 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 293 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 1712 | 0.020 |
Why?
|
| Brain | 1 | 2023 | 3170 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 4711 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1610 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 817 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 2332 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 1081 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 1218 | 0.020 |
Why?
|
| RNA, Helminth | 1 | 2006 | 10 | 0.020 |
Why?
|
| Binding Sites | 1 | 2006 | 1136 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2006 | 748 | 0.010 |
Why?
|